XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss per Common Share (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Anti-dilutive securities excluded from the computation of earnings per share
The following potentially dilutive securities were excluded from the computation of earnings per share as of March 31, 2022 and 2021 because their effects would be anti-dilutive:
 
     
                    
     
                    
 
 
  
March 31,
 
 
  
2022
 
  
2021
 
Stock options
  
 
2,238,103
 
  
 
1,078,499
 
Common stock warrants - equity
  
 
3,894,498
 
  
 
3,994,107
 
Assumed conversion of Series E and Series
E-1
Preferred Stock
  
 
1,135,721
 
  
 
2,048,101
 
Assumed conversion of convertible notes
  
 
488,031
 
  
 
146,288
 
    
 
 
    
 
 
 
Total
  
 
7,756,353
 
  
 
7,266,995
 
    
 
 
    
 
 
 
Summary of reconciliation of weighted average shares outstanding calculation The following table provides a reconciliation of the weighted average shares outstanding calculation for the three months ended March 31, 2022 and 2021:
     
                    
     
                    
 
 
  
Three months ended March 31,
 
 
  
2022
 
  
2021
 
Weighted average shares issued
  
 
7,906,728
 
  
 
6,125,922
 
Weighted average
pre-funded
warrants
  
 
283,755
 
  
 
371,000
 
    
 
 
    
 
 
 
Weighted average shares outstanding
  
 
8,190,483
 
  
 
6,496,922